Related Experiment Videos
Down-regulation of c-Ki-ras2 gene expression associated with morphologic differentiation in human embryonal carcinoma
1Laboratory of Cellular Oncology, National Cancer Institute, NIH, Bethesda, MD.
Abstract:
A pluripotent human embryonal carcinoma (EC) clone, NT2/D1, which was derived from the Tera-2 cell line, was induced to differentiate into cells with neuronal-like cell morphology by treatment with berberine, an alkaloid derived from a Chinese herbal medicine (Huang Lien). As early as one day after 24-hour treatment of cells with berberine at a nontoxic dose of 0.1 mg/ml in culture medium, the cells started to show morphologic changes, developing into terminally differentiated neuronal-like cells with long, inter-connecting network cellular structures. This process was much faster as compared with that induced by treatment with retinoic acid (RA), which took at least several days to develop. Unlike RA, berberine could not induce murine EC cell line, F9, to differentiate into endodermal cells. It was also found that although the NT2/D1 cell clone exhibited amplification and enhanced mRNA expression of c-Ki-ras2 gene as did the parent cell line, a marked down-regulation of c-Ki-ras2 mRNA expression was observed. However, there was no change in actin mRNA expression even after differentiation had occurred. Thus, morphologic differentiation of EC cells into neuronal-like cells was found to be associated with down-regulation of a protooncogene which plays some definite role in oncogenesis. The mechanism by which berberine induces differentiation in these cells needs further investigation.
Insights
Berberine rapidly induces neuronal differentiation in human embryonal carcinoma cells. This process involves down-regulation of the protooncogene c-Ki-ras2, offering a novel approach to studying cell differentiation.
Area of Science:
- Cell Biology
- Developmental Biology
- Pharmacology
Background:
- Pluripotent human embryonal carcinoma (EC) cells, like the NT2/D1 clone, can be induced to differentiate into various cell types.
- Retinoic acid (RA) is a known inducer of neuronal differentiation in EC cells, but the process is relatively slow.
Purpose of the Study:
- To investigate the potential of berberine, an alkaloid from Chinese herbal medicine, to induce neuronal differentiation in NT2/D1 cells.
- To compare the speed and efficacy of berberine-induced differentiation with retinoic acid.
- To explore the molecular changes associated with berberine-induced differentiation, particularly the expression of c-Ki-ras2 protooncogene.
Main Methods:
- Treatment of NT2/D1 cells with berberine at a nontoxic dose (0.1 mg/ml).
- Morphological assessment of cells to observe differentiation into neuronal-like cells.
- Comparison of differentiation kinetics with retinoic acid treatment.
- Analysis of c-Ki-ras2 and actin mRNA expression levels using molecular techniques.
Main Results:
- Berberine rapidly induced morphological differentiation of NT2/D1 cells into neuronal-like cells within 24 hours, significantly faster than retinoic acid.
- Berberine did not induce endodermal differentiation in the murine F9 EC cell line, unlike its effect on NT2/D1 cells.
- Differentiation was associated with a marked down-regulation of c-Ki-ras2 mRNA expression, while actin mRNA expression remained unchanged.
Conclusions:
- Berberine is a potent and rapid inducer of neuronal differentiation in human embryonal carcinoma cells.
- The differentiation process mediated by berberine is linked to the down-regulation of the c-Ki-ras2 protooncogene.
- Further research is needed to elucidate the precise molecular mechanisms underlying berberine's differentiation-inducing effects.